Axiostat, the first US Food and Drug Administration (USFDA) approved wound dressing product from India is a user-friendly, compact pack of 8X8 centimeters which ceases unrestrained bleeding from wounds. When applied on a wound, the patch acts on the blood and forms a clot in a minute and turns into a very sticky adhesive patch.
Kindbody, a women-empowered startup was launched on Tuesday by Gina Bartasi, Progyny founder and other women leaders, remarkably co-founders Fahimeh Sasan, MD, from Mount Sinai, and Joanne Schneider, former product leader at Google and Flatiron Health, and Cynthia Hudson, clinical embryology and IVF expert and owner of Manhattan Fertility Specialists.
New sponsor OCA Ventures along with existing financiers have granted $1 million in Series A funding to PatientWisdom, a digital health corporation working on real-world data compilation tools. The company’s total funding is now worth $3.45 million.
Research in prostate cancer could speed up drastically with a new breakthrough in prostate cancer cells grown in-vitro which could transform future drug trials.
HiFiBiO Therapeutics is aspiring to work on antibody therapies for different gastrointestinal diseases, cancers and other disorders by signing a pact with Japanese Pharma and biotech company Takeda.
Phillips-Medisize introduced a connected health platform to enhance the way people take medication while using connected health devices.
Pfizer objected to the use of its drugs for lethal injection procedures last year by asking states to return the drugs immediately for a refund. But not all of them have halted its utilization. Hence, with an execution planned in Nebraska dated Aug. 14, a state senator is urging Pfizer to prosecute if the drug usage is not halted.
Adherium, the makers of inhaler sensors, has received 510(k) US-FDA clearance for the sales of its Hailie sensor, previously known as Smartinhaler. The individual versions of this device were previously cleared for use with the asthma inhalers like Ventolin HFA, ProAir HFA, and Flovent HFA.
A prospective, observational study published in Annals of the Rheumatic Diseases, showed that patients at risk of autoimmune connective tissue disease who evolved to definite disease had high interferon levels and a family history of autoimmune rheumatic disease, foreseeing a link between the interferon scores and disease progression.
A large database study showed that patients who were given a corticosteroid injection within 6 months preceding a rotator cuff repair, possess a high risk of undergoing a revision rotator cuff surgery in the next 3 years.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.